Skip to main content
Erschienen in: Supportive Care in Cancer 8/2011

01.08.2011 | Original Article

Long-term quality of life after radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial

verfasst von: Katherine Regan Sterba, Richard J. Swartz, Karen Basen-Engquist, Peter C. Black, Curtis A. Pettaway

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We examined quality of life in spouses of men in the Post-Adjuvant Androgen Deprivation trial after radical prostatectomy.

Methods

Men at high risk of prostate cancer recurrence were randomized to receive androgen deprivation therapy or observation. Forty-three couples completed telephone interviews every 6 months for 2 years assessing women’s mood disturbance, mental and physical health, and sexual function and bother as well as men’s symptoms and sociodemographic and marital variables. We used linear mixed modeling to explore relationships between wives’ quality of life and time, treatment group, and men’s symptoms.

Results

Women’s mental health functioning improved over time (p < 0.05). Furthermore, women with husbands in the observation group had worse mood disturbance (p = 0.01) and poorer mental health (p = 0.02) than women with husbands in treatment. Men’s symptoms were associated with worse physical health in wives (p = 0.02). Women also reported worse sexual function at 18 and 24 months compared with baseline (p = 0.02), but ratings of sexual bother were unrelated to time, treatment, and symptoms.

Conclusions

These exploratory results are consistent with research demonstrating that spousal cancer-related distress decreases over time. Treatment group differences suggest that an examination of caregiving in the context of uncertainty is warranted. Also, the physical burden of caregiving may intensify when men have more symptoms. To inform interventions, future studies should clarify how treatment and symptoms influence wives’ distress by examining expectations and communication.
Literatur
1.
Zurück zum Zitat American Cancer Society (2009) Cancer facts & figures 2009. American Cancer Society, Atlanta American Cancer Society (2009) Cancer facts & figures 2009. American Cancer Society, Atlanta
3.
Zurück zum Zitat Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH (1995) Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273:129–135PubMedCrossRef Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH (1995) Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273:129–135PubMedCrossRef
4.
Zurück zum Zitat Clark JA, Talcott JA (2006) Confidence and uncertainty long after initial treatment for early prostate cancer: survivors’ views of cancer control and the treatment decisions they made. J Clin Oncol 24(27):4457–4463PubMedCrossRef Clark JA, Talcott JA (2006) Confidence and uncertainty long after initial treatment for early prostate cancer: survivors’ views of cancer control and the treatment decisions they made. J Clin Oncol 24(27):4457–4463PubMedCrossRef
5.
Zurück zum Zitat Holzbeierlein JM, Castle E, Thrasher JB (2004) Complications of androgen deprivation therapy: prevention and treatment. Oncology 18:303–309PubMed Holzbeierlein JM, Castle E, Thrasher JB (2004) Complications of androgen deprivation therapy: prevention and treatment. Oncology 18:303–309PubMed
6.
Zurück zum Zitat Black PC, Basen-Engquist K, Wang X, Swartz RJ, Eddings T, Matin SF, Swanson D, Wood CG, Pisters LL, Babaian RJ, Troncoso P, Pettaway CA (2007) A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the postoperative adjuvant androgen deprivation trial. BJU Int 100:63–69PubMedCrossRef Black PC, Basen-Engquist K, Wang X, Swartz RJ, Eddings T, Matin SF, Swanson D, Wood CG, Pisters LL, Babaian RJ, Troncoso P, Pettaway CA (2007) A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the postoperative adjuvant androgen deprivation trial. BJU Int 100:63–69PubMedCrossRef
7.
Zurück zum Zitat Eton DT, Lepore SJ (2002) Prostate cancer and health-related quality of life: a review of the literature. Psychooncology 11(4):307–326PubMedCrossRef Eton DT, Lepore SJ (2002) Prostate cancer and health-related quality of life: a review of the literature. Psychooncology 11(4):307–326PubMedCrossRef
8.
Zurück zum Zitat Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, Deapen D, Gilliland F, Hoffman R, Stephenson RA, Potosky AL, Stanford JL (2007) General quality of life two years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 21(6):1147–1154CrossRef Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, Deapen D, Gilliland F, Hoffman R, Stephenson RA, Potosky AL, Stanford JL (2007) General quality of life two years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 21(6):1147–1154CrossRef
9.
Zurück zum Zitat Couper J, Bloch S, Love A, MacVean M, Duchesne GM, Kissane D (2006) Psychological adjustment of female partners of men with prostate cancer: a review of the literature. Psychooncology 15:937–953PubMedCrossRef Couper J, Bloch S, Love A, MacVean M, Duchesne GM, Kissane D (2006) Psychological adjustment of female partners of men with prostate cancer: a review of the literature. Psychooncology 15:937–953PubMedCrossRef
10.
Zurück zum Zitat Thornton AA, Perez MA, Meyerowitz BE (2004) Patient and partner quality of life and psychosocial adjustment following radical prostatectomy. J Clin Psychol Med Settings 11(1):15–30CrossRef Thornton AA, Perez MA, Meyerowitz BE (2004) Patient and partner quality of life and psychosocial adjustment following radical prostatectomy. J Clin Psychol Med Settings 11(1):15–30CrossRef
11.
Zurück zum Zitat Northouse LL, Mood DW, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, Sanda MG, Kershaw T (2007) Living with prostate cancer: patients’ and spouses’ psychosocial status and quality of life. J Clin Oncol 25(27):4171–4177PubMedCrossRef Northouse LL, Mood DW, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, Sanda MG, Kershaw T (2007) Living with prostate cancer: patients’ and spouses’ psychosocial status and quality of life. J Clin Oncol 25(27):4171–4177PubMedCrossRef
12.
Zurück zum Zitat Kornblith AB, Herndon JE, Zuckerman E, Godley PA, Savarese D, Vogelzang NJ, Holland JC for the Cancer and Leukemia Group B (CALGB) (2001) The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: a feasibility study. Ann Oncol 12:633–641CrossRef Kornblith AB, Herndon JE, Zuckerman E, Godley PA, Savarese D, Vogelzang NJ, Holland JC for the Cancer and Leukemia Group B (CALGB) (2001) The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: a feasibility study. Ann Oncol 12:633–641CrossRef
13.
Zurück zum Zitat Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT (2008) Quality of life and satisfaction with outcome among prostate cancer survivors. New Engl J Med 358:1250–1261PubMedCrossRef Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT (2008) Quality of life and satisfaction with outcome among prostate cancer survivors. New Engl J Med 358:1250–1261PubMedCrossRef
14.
Zurück zum Zitat Cliff AM, MacDonagh RP (2000) Psychosocial morbidity in prostate cancer: II. A comparison of patients and partners. BJU Int 86:834–839PubMedCrossRef Cliff AM, MacDonagh RP (2000) Psychosocial morbidity in prostate cancer: II. A comparison of patients and partners. BJU Int 86:834–839PubMedCrossRef
15.
Zurück zum Zitat Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long term biochemical disease-free and cancer specific survival following anatomic radical retropubic prostatectomy. Urol Clin N Am 28:555–565CrossRef Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long term biochemical disease-free and cancer specific survival following anatomic radical retropubic prostatectomy. Urol Clin N Am 28:555–565CrossRef
16.
Zurück zum Zitat Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H (2002) Radical prostatectomy for pathological gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol 167:117–122PubMedCrossRef Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H (2002) Radical prostatectomy for pathological gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol 167:117–122PubMedCrossRef
17.
Zurück zum Zitat Mian BM, Troncoso P, Okihara K, Bhadkamkar V, Johnston D, Reyes AO, Babaian RJ (2002) Outcome of patients with gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol 167:1675–1680PubMedCrossRef Mian BM, Troncoso P, Okihara K, Bhadkamkar V, Johnston D, Reyes AO, Babaian RJ (2002) Outcome of patients with gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol 167:1675–1680PubMedCrossRef
18.
Zurück zum Zitat McNair PM, Lorr M, Droppleman LF (1981) POMS manual, 2nd edn. Educational and Industrial Testing Service, San Diego McNair PM, Lorr M, Droppleman LF (1981) POMS manual, 2nd edn. Educational and Industrial Testing Service, San Diego
19.
Zurück zum Zitat Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36®): I. Conceptual framework and item selection. Med Care 30(6):473–483PubMedCrossRef Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36®): I. Conceptual framework and item selection. Med Care 30(6):473–483PubMedCrossRef
20.
Zurück zum Zitat Ware JE, Kosinski M (2001) SF-36 physical and mental health summary scales: a manual for users of version 1, 2nd edn. Quality Metric Incorporated, Lincoln Ware JE, Kosinski M (2001) SF-36 physical and mental health summary scales: a manual for users of version 1, 2nd edn. Quality Metric Incorporated, Lincoln
21.
Zurück zum Zitat McHorney CA, Ware JE, Raczek AE (1993) The MOS 36-item short-form health survey (SF-36®): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31(3):247–263PubMedCrossRef McHorney CA, Ware JE, Raczek AE (1993) The MOS 36-item short-form health survey (SF-36®): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31(3):247–263PubMedCrossRef
22.
Zurück zum Zitat Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH (1998) The UCLA prostate cancer index: development, reliability, and validity of a health-related quality of life measure. Med Care 36:1002–1112PubMedCrossRef Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH (1998) The UCLA prostate cancer index: development, reliability, and validity of a health-related quality of life measure. Med Care 36:1002–1112PubMedCrossRef
23.
Zurück zum Zitat Moinpour CM, Savage MJ, Troxel A, Lovato LC, Eisenberger M, Veith RW, Higgins B, Skeel R, Yee M, Blumenstein BA, Crawford ED, Meyskens FL (1998) Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. J Natl Cancer Inst 90(20):1537–1544PubMedCrossRef Moinpour CM, Savage MJ, Troxel A, Lovato LC, Eisenberger M, Veith RW, Higgins B, Skeel R, Yee M, Blumenstein BA, Crawford ED, Meyskens FL (1998) Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. J Natl Cancer Inst 90(20):1537–1544PubMedCrossRef
24.
Zurück zum Zitat Spanier GB (1976) Measuring dyadic adjustment: new scales for assessing the quality of marriage and similar dyads. J Marriage Fam 38(1):15–28CrossRef Spanier GB (1976) Measuring dyadic adjustment: new scales for assessing the quality of marriage and similar dyads. J Marriage Fam 38(1):15–28CrossRef
25.
Zurück zum Zitat Blackwell E, Mendes de Leon C, Miller GE (2006) Applying mixed regression models to the analysis of repeated-measures data in psychosomatic medicine. Psychsom Med 68:870–878CrossRef Blackwell E, Mendes de Leon C, Miller GE (2006) Applying mixed regression models to the analysis of repeated-measures data in psychosomatic medicine. Psychsom Med 68:870–878CrossRef
26.
Zurück zum Zitat Diggle PJ, Heagerty P, Liang K-Y, Zeger SL (2002) Analysis of longitudinal data, 2nd edn. Oxford University Press, Oxford Diggle PJ, Heagerty P, Liang K-Y, Zeger SL (2002) Analysis of longitudinal data, 2nd edn. Oxford University Press, Oxford
27.
Zurück zum Zitat Cumming G (2009) Inference by eye: reading the overlap of independent confidence intervals. Stat Med 28:205–220PubMedCrossRef Cumming G (2009) Inference by eye: reading the overlap of independent confidence intervals. Stat Med 28:205–220PubMedCrossRef
28.
Zurück zum Zitat Krantz DH (1999) The null hypothesis testing controversy in psychology. J Am Stat Assoc 44:1372–1381CrossRef Krantz DH (1999) The null hypothesis testing controversy in psychology. J Am Stat Assoc 44:1372–1381CrossRef
29.
Zurück zum Zitat Schenker N, Gentleman JF (2001) On judging the significance of differences by examining the overlap between confidence intervals. Am Stat 55(3):182–186CrossRef Schenker N, Gentleman JF (2001) On judging the significance of differences by examining the overlap between confidence intervals. Am Stat 55(3):182–186CrossRef
30.
Zurück zum Zitat Blouin DC, Riopelle AJ (2005) On confidence intervals for within-subjects designs. Psychol Methods 10(4):397–412PubMedCrossRef Blouin DC, Riopelle AJ (2005) On confidence intervals for within-subjects designs. Psychol Methods 10(4):397–412PubMedCrossRef
31.
Zurück zum Zitat Gelman A, Stern H (2006) The difference between “significant” and “not significant” is not itself statistically significant. Am Stat 60(4):328–331CrossRef Gelman A, Stern H (2006) The difference between “significant” and “not significant” is not itself statistically significant. Am Stat 60(4):328–331CrossRef
32.
Zurück zum Zitat Hewitt ME, Greenfield S, Stovall E (eds) (2006) From cancer patient to cancer survivor: lost in translation. The National Academies Press, Washington Hewitt ME, Greenfield S, Stovall E (eds) (2006) From cancer patient to cancer survivor: lost in translation. The National Academies Press, Washington
33.
Zurück zum Zitat Germino BB, Mishel MH, Belyea M, Harris L, Ware A, Mohler J (1998) Uncertainty in prostate cancer: ethnic and family patterns. Cancer Pract 6(2):107–113PubMedCrossRef Germino BB, Mishel MH, Belyea M, Harris L, Ware A, Mohler J (1998) Uncertainty in prostate cancer: ethnic and family patterns. Cancer Pract 6(2):107–113PubMedCrossRef
34.
Zurück zum Zitat Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC (1994) Quality of life of patients with prostate cancer and their spouses: the value of a database in clinical care. Cancer 73(13):2791–2802PubMedCrossRef Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC (1994) Quality of life of patients with prostate cancer and their spouses: the value of a database in clinical care. Cancer 73(13):2791–2802PubMedCrossRef
35.
Zurück zum Zitat Kurtz ME, Kurtz JC, Given CW, Given B (1995) Relationship of caregiver reactions and depression to cancer patients’ symptoms, functional status and depression—a longitudinal view. Soc Sci Med 40(6):837–846PubMedCrossRef Kurtz ME, Kurtz JC, Given CW, Given B (1995) Relationship of caregiver reactions and depression to cancer patients’ symptoms, functional status and depression—a longitudinal view. Soc Sci Med 40(6):837–846PubMedCrossRef
36.
Zurück zum Zitat Siegel K, Raveis VH, Mor V, Houts P (1991) The relationship of spousal caregiver burden to patient disease and treatment-related conditions. Ann Oncol 2:511–516PubMed Siegel K, Raveis VH, Mor V, Houts P (1991) The relationship of spousal caregiver burden to patient disease and treatment-related conditions. Ann Oncol 2:511–516PubMed
37.
Zurück zum Zitat Nijboer C, Tempelaar R, Sanderman R, Triemstra M, Spruijt RJ, Van den Bos G (1998) Cancer and caregiving: the impact on the caregiver’s health. Psychooncology 7:3–13PubMedCrossRef Nijboer C, Tempelaar R, Sanderman R, Triemstra M, Spruijt RJ, Van den Bos G (1998) Cancer and caregiving: the impact on the caregiver’s health. Psychooncology 7:3–13PubMedCrossRef
38.
Zurück zum Zitat Perez MA, Skinner EC, Meyerowitz BE (2002) Sexuality and intimacy following radical prostatectomy: patient and partner perspectives. Health Psychol 21(3):281–293CrossRef Perez MA, Skinner EC, Meyerowitz BE (2002) Sexuality and intimacy following radical prostatectomy: patient and partner perspectives. Health Psychol 21(3):281–293CrossRef
39.
Zurück zum Zitat Soloway CT, Soloway MS, Kim SS, Kava BR (2005) Sexual, psychological and dyadic qualities of the prostate cancer ‘couple’. BJU Int 95:780–785PubMedCrossRef Soloway CT, Soloway MS, Kim SS, Kava BR (2005) Sexual, psychological and dyadic qualities of the prostate cancer ‘couple’. BJU Int 95:780–785PubMedCrossRef
40.
Zurück zum Zitat Bodenmann G (1997) Dyadic coping—a systemic-transactional conceptualization of stress and coping among couples: theory and empirical findings. Eur Rev Appl Psychol 47:137–140 Bodenmann G (1997) Dyadic coping—a systemic-transactional conceptualization of stress and coping among couples: theory and empirical findings. Eur Rev Appl Psychol 47:137–140
41.
Zurück zum Zitat Burish TG, Snyder SL, Jenkins RA (1991) Preparing patients for cancer chemotherapy: effect of coping preparation and relaxation interventions. J Consult Clin Psychol 59:518–525PubMedCrossRef Burish TG, Snyder SL, Jenkins RA (1991) Preparing patients for cancer chemotherapy: effect of coping preparation and relaxation interventions. J Consult Clin Psychol 59:518–525PubMedCrossRef
42.
Zurück zum Zitat Merluzzi TV, Martinez Sanchez MA (1997) Assessment of self-efficacy and coping with cancer: development and validation of the cancer behavior inventory. Health Psychol 16(2):163–170PubMedCrossRef Merluzzi TV, Martinez Sanchez MA (1997) Assessment of self-efficacy and coping with cancer: development and validation of the cancer behavior inventory. Health Psychol 16(2):163–170PubMedCrossRef
43.
Zurück zum Zitat Badr H, Taylor CL (2009) Sexual dysfunction and spousal communication in couples coping with prostate cancer. Psychooncology 18(7):735–746PubMedCrossRef Badr H, Taylor CL (2009) Sexual dysfunction and spousal communication in couples coping with prostate cancer. Psychooncology 18(7):735–746PubMedCrossRef
44.
Zurück zum Zitat Manne S, Badr H, Zaider T, Nelson C, Kissane D (2010) Cancer-related communication, relationship intimacy and psychological distress among couples coping with localized prostate cancer. J Cancer Surviv 4(1):74–85PubMedCrossRef Manne S, Badr H, Zaider T, Nelson C, Kissane D (2010) Cancer-related communication, relationship intimacy and psychological distress among couples coping with localized prostate cancer. J Cancer Surviv 4(1):74–85PubMedCrossRef
Metadaten
Titel
Long-term quality of life after radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial
verfasst von
Katherine Regan Sterba
Richard J. Swartz
Karen Basen-Engquist
Peter C. Black
Curtis A. Pettaway
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0916-8

Weitere Artikel der Ausgabe 8/2011

Supportive Care in Cancer 8/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.